Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

Clinical trial NCT00835328 · TERMINATED

Trial details

NCT number: NCT00835328
Sponsor: Diva De Leon
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Congenital Hyperinsulinism

Start date: 2009-08-26
Primary completion: 2017-01-28
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.